1. Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer. (April 2017) Authors: Vincent, Mark D; Breadner, Daniel; Soulieres, Denis; Kerr, Ian G; Sanatani, Michael; Kocha, Walter; Klimo, Peter; MacKenzie, Mary J; O'Connell, Anne; Whiston, Frances; Malpage, Anne S; Stitt, Larry; Welch, Stephen A Journal: Future oncology Issue: Volume 13:Number 9(2017) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗